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We report a case of paradoxical worsening of tuberculous chorioretinitis after initiation of anti-tuberculous therapy
(ATT). The patient had left panuveitis with tuberculous chorioretinitis and was started on systemic ATT and oral steroids
a week later. However, he developed paradoxical worsening 2 months after initiation of therapy. He was continued on
ATT, oral steroids and intravitreal amikacin with resolution of the chorioretinal lesion subsequently. Ocular tuberculosis
often poses a diagnostic challenge, and clinicians should be aware of the possibility of paradoxical worsening despite
appropriate ATT. Clinicians should strongly consider starting oral steroids concurrently with ATT when managing ocular
tuberculosis.
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Introduction
Tuberculosis (TB), caused by Mycobacterium tuberculosis,
can cause multi-systemic granulomatous inflammation,
most commonly in the pulmonary system. Although
ocular involvement is relatively uncommon, it is still a
well-known extrapulmonary manifestation [1]. It often
poses a diagnostic challenge to ophthalmologists, and
management should be prompt as it can sight saving.
The commonest manifestation of ocular tuberculosis is in
the uveal tract and usually presents as a posterior uveitis,
of which choroidal tuberculomas are the commonest [1].
With anti-tuberculous therapy (ATT), posterior uveitis
is expected to resolve within 4 to 6 weeks [1]. We report a
rare case of paradoxical worsening of ocular TB after initi-
ation of ATT.Report
A 50-year-old man with past medical history of diabetes
mellitus presented with 1 week history of left eye blurring
of vision and mild discomfort. His Snellen visual acuity
was 6/7.5 in the right eye and 6/15 in the left eye. Anterior
segment examination revealed signs of uveitis with* Correspondence: rupeshttsh@gmail.com
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provided the original work is properly creditedmultiple keratic precipitates, anterior chamber cells 1+ and
retrolental cells 2+. Fundus examination showed significant
vitritis, vasculitis and a well defined yellowish-white chor-
ioretinal lesion superior to the macula (Fig. 1a, b). Anterior
and posterior segment examination of the right eye was
normal. He underwent a vitreous tap which identified
mycobacterial DNA via polymerase chain reaction (PCR).
The PCR test was the Probetec DTB assay (Becton
Dickinson), and the gene sequences targeted were IS6110
and 16S rRNA. His Mantoux test measured 25 mm and
chest X-ray was clear. Full blood count revealed lympho-
cytosis, and other systemic investigations including HIV
and syphilis were negative. The working diagnosis was that
of a left eye panuveitis with tuberculous chorioretinitis,
and he was started on ATT (6 months course of oral ri-
fampicin, isoniazid and ethambutol) by the infectious
disease specialist. He was subsequently started on oral
prednisolone 40 mg a week later. Fundus fluorescein
angiogram (Fig. 2a–c) revealed non-perfusion peripheral
to the choroidal lesion representing a branch retinal vein
occlusion, and he underwent a sectoral panretinal photo-
coagulation. In the third month of treatment, the patient
was noted to have clinical deterioration with decrease in
visual acuity to hand movement and progression of the
chorioretinal lesion to the macula (Fig. 3). He underwent a
repeat vitreous tap for which mycobacterial DNA PCRicle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Fig. 1 a, b Fundus photos of left eye showing vitritis, vasculitis and chorioretinitis superior to the macula
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cin 0.4 mg/0.1 ml. The patient was continued on systemic
oral ATT and steroids, and the lesion slowly resolved, be-
coming smaller in size and developing fibrosis and later
scarring. The patient’s final visual acuity at last follow-up
was 6/120. The patient has given consent for the report to
be published.
Discussion
In systemic tuberculosis, paradoxical worsening has
been described as worsening of intracranial tubercu-
loma, meningeal disease, tuberculous meningeal radi-
culitis, pleural effusion and abdominal tuberculosis
[1]. Paradoxical worsening after antibiotic therapy has
been described in other conditions and is termed Jarisch-
Herxheimer reaction (JHR) when associated with the
treatment of secondary syphilis, manifesting with systemic
symptoms such as fever, headache and sweating [2].
Isolated intraocular JHR has been previously reported
in treatment of ocular syphilis with rapid visual loss [3].
Worsening after initial therapy has also been describedFig. 2 Fundus fluorescein angiography in early (a), mid (b) and late (c)in other conditions such as Whipple’s disease [4] and
Lyme disease [5].
The pathogenesis of paradoxical worsening in tubercu-
losis is not well understood. Proposed mechanisms in-
clude release of mycobacterial antigens after ATT and
delayed hypersensitivity [1]. It can clinically manifest as
rapid worsening of vitritis and chorioretinitis and has
been reported to have good response to the addition of
oral steroid [6–8] (Fig. 4).
In a case series published by Hamade et al. [9], 20 pa-
tients with presumed ocular tuberculosis treated with
ATT only had complete resolution with no complication.
On the other hand, although paradoxical worsening of
ocular tuberculosis after treatment with ATT is rare, there
have been a few cases reported so far [6–8, 10]. Interest-
ingly, in a case series of 110 patients published by Gupta
et al. [11], 14 % of patients with tubercular serpiginous-
like choroiditis had continued progression while on treat-
ment. One patient was on corticosteroids only, while the
rest were on ATT and corticosteroids when they were ob-
served to have continued progression. They were managedphases showing non-perfusion peripheral to area of chorioretinitis
Fig. 3 Fundus photo of the left eye showing progression of chorioretinitis to the macula
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dosage of corticosteroids or other immunosuppressants
such as azathioprine, and these patients subsequently
achieved clinical resolution. These studies demonstrate
variability in response of ocular TB to different treatment
regimes and highlight a need for future studies with a larger
population of ocular tuberculosis to better evaluate the
ideal treatment regime of ATT with or without adjunctive
systemic steroids.
Our patient developed paradoxical worsening despite
already being on oral steroid and ATT. In our case, oral
steroid was initiated 1 week after the initiation of ATT.
This is unique among other reported cases where steroidFig. 4 Diagrammatic representation of clinical course of
ocular tuberculosiswas only added to the treatment regime after development
of ocular paradoxical worsening or started concurrently
with ATT [11]. It is important to highlight that rifampicin,
which is usually part of the standard regimen of ATT, may
reduce bioavailability of prednisolone by 66 % [12]. This
should be taken into consideration in order to achieve the
therapeutic dose of systemic steroids in such patients. The
benefit of starting oral steroids concurrently with ATT re-
mains to be seen and needs further studies.
Conclusion
Ocular tuberculosis often poses a diagnostic and manage-
ment challenge. Clinicians should be aware of the possibil-
ity of paradoxical worsening of ocular tuberculosis despite
initiating ATT and consider starting systemic oral steroids
concurrently and at the right dosage when managing ocular
tuberculosis.
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